COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

August 03, 2020 00:38:27
Episode Cover

The Critically Ill ED Boarder

Emergency department (ED) visits for critically ill patients has nearly doubled over the past decade.  Unfortunately, ED boarding of critically ill patients awaiting ICU...

Listen

Episode 0

February 14, 2017 00:29:35
Episode Cover

Surviving Sepsis Campaign 2016 Update

The SSC recently published its new recommendations for the management of sepsis and septic shock.  We discuss the key changes and controversies that you...

Listen

Episode 0

March 18, 2022 00:30:35
Episode Cover

The Critically Ill Patient with HHS

Hyperglycemic hyperosmolar syndrome (HHS) is a potentially life-threatening hyperglycemic emergency that has a mortality that can be 10 times as high compared with patients...

Listen